A significantly lower B-cell number in RA than in OA suggests that these cells actively emigrate from RA bone marrow to peripheral blood and affected joints.
Significantly lower B-cell numbers in RA than in OA suggest that these cells actively emigrate from RA bone marrow to peripheral blood and affected joints.
Regardless of the dose-response relationship, an estimation of the mean absorbed dose to the bone marrow in PRRT must be considered important because its viability will set the limits for future therapies affecting the bone marrow and affect the risk of developing serious long-term toxicity.
The juxtacrine interaction of BMSCs and macrophages occurring in the bone marrow may affect the surrounding cells in the bone marrow environment by releasing vital signals.
Infiltration of fat in bone marrow could affect osteoblast function and differentiation through paracrine/endocrine effects of secretory products and adipocytokines [ 18, 19].
First, the dose and type of T-cell subsets (i.e. CD4+, CD8+ or TReg cells) that are transferred with donor bone marrow can affect the severity of the disease (Sprent et al., 1988; Korngold, 1992; Edinger et al., 2003).
The rationale is that absorbed arsenic in the blood circulation can reach to the bone marrow and may affect the cell survival of MSCs.
To address whether bone marrow is affected in the course of arthritis, human tumor necrosis factor transgenic (hTNFtg) mice, constituting an established animal model of human RA, were examined for bone marrow changes.
In particular, we reported that CML cells release exosomes, and that the addition of these vesicles to vascular endothelial cells, as well as to bone marrow stromal cells, affects in vitro and in vivo tumor progression [ 6, 8, 9].
Bone marrow transplant, the transfer of bone marrow from a healthy donor to a recipient whose own bone marrow is affected by disease.
